Literature DB >> 314874

Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice.

S Kai, J Tanaka, K Nomoto, M Torisu.   

Abstract

The effects of the anti-tumour agent OK-432 on the immune response to hamster erythrocytes (HRBC) and nucleated chicken erythrocytes (CRBC) were studied in inbred SL mice. Mice were treated repeatedly with OK-432 before immunization with erythrocytes in saline. The cytotoxicity of CRBC-primed spleen cells, as demonstrated by 51Cr release from labelled CRBC, was markedly increased by treatment with OD-432. The delayed footpad reaction to CRBC was significantly augmented by treatment with OK-432. These results in mice indicate that OK-432 can enhance the cellular immune responses which require the contribution of T cells. Such an activation of T cells by OK-432 was observed in the humoral immune response to a trinitrophenyl group. Augmentation of anti-hapten antibody production, suggesting the enhancement of helper T cell activity by OK-432, was noticed after immunization with trinitrophenyl conjugated to erythrocytes. Furthermore, this enhancement of helper T cell activity by OK-432 was confirmed by utilizing an adoptive transfer system. These results support the possibility that T cell activation may be one of the important effects of OK-432 as an immunopotentiator.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314874      PMCID: PMC1537677     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Allergy in experimental mouse tuberculosis.

Authors:  D F GRAY; P A JENNINGS
Journal:  Am Rev Tuberc       Date:  1955-08

2.  Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan.

Authors:  M Torisu; M Fukawa; M Nishimura; H Harasaki; S Kai; J Tanaka
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Effect of carrier priming on antibody avidity in the in vivo and in vitro immune response.

Authors:  G Doria; G Agarossi; D Boraschi; M Antonietta
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

4.  Macrophages bearing hapten-carrier molecules as foci inducers for T and B lymphocyte interaction.

Authors:  B A Askonas; G E Roelants
Journal:  Eur J Immunol       Date:  1974-01       Impact factor: 5.532

5.  Immunogenicity of macrophage-bound antigens: the requirement for hapten and carrier determinants to be on the same molecule for T and B lymphocyte collaboration.

Authors:  E R Unanue; D H Katz
Journal:  Eur J Immunol       Date:  1973-09       Impact factor: 5.532

Review 6.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

7.  Direct cytotoxicity against chicken erythrocytes in mice. I. Fundamental nature of T cell-mediated cytotoxicity.

Authors:  C Kubo; K Nomoto; M Sato; K Takeya
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

8.  Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy.

Authors:  I Kimura; T Onoshi; S Yasuhara; T Watanabe; M Sugiyama; K Hiraki
Journal:  Acta Med Okayama       Date:  1974-12       Impact factor: 0.892

9.  Effects of BCG (Bacillus Calmette-Guérin) vaccines on immune responses in mice. I. Possible effect of BCG on helper T cells.

Authors:  Y Kitamura; K Nomoto; M Torisu; K Takeya
Journal:  Jpn J Microbiol       Date:  1976-08

10.  Relationships among differentiated T-cell subpopulations. I. Dissociated development of tuberculin type hypersensitivity, Jones-Mote type hypersensitivity and activation of helper function.

Authors:  Y Ohmichi; K Nomoto; H Yamada; K Takeya
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

View more
  6 in total

1.  Immunological analysis and characterization of lymphocyte subsets in specimens of human hepatocellular carcinomas and metastatic liver cancers.

Authors:  K Yuh; M Shimizu; S Aoyama; I Ichihara; H Watanabe; M Okumura; M Kikuchi
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Vitamin E and immune response. I. Enhancement of helper T cell activity by dietary supplementation of vitamin E in mice.

Authors:  J Tanaka; H Fujiwara; M Torisu
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

3.  Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.

Authors:  K Sugimachi; Y Maehara; K Akazawa; Y Kondo; Y Kunii; M Kitamura; H Yamaoka; Y Takahashi; T Kito; M Katou
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  A controlled study of maintenance chemoimmunotherapy vs immunotherapy alone immediately following palliative gastrectomy and induction chemoimmunotherapy for advanced gastric cancer. Tokai cooperative study group for adjuvant chemoimmunotherapy of stomach cancer.

Authors:  M Yasue; M Murakami; H Nakazato; T Suchi; K Ota
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.

Authors:  Y Maehara; S Inutsuka; H Takeuchi; H Baba; H Kusumoto; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Promotion of hepatic metastases by liver resection in the rat.

Authors:  J Mizutani; T Hiraoka; R Yamashita; Y Miyauchi
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.